Patent details

EP2542078 Title: TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD

Basic Information

Publication number:
EP2542078
PCT Application Number:
PCT/US/2011/026879
Type:
European Patent Granted for LU
Legal Status:
Lapsed
Application number:
EP117512954
PCT Publication Number:
WO/2011/109526
First applicant's nationality:
Translation Language:
EPO Publication Language:
English
English Title of Invention:
TREATMENT OF LUPUS NEPHRITIS USING LAQUINIMOD
French Title of Invention:
TRAITEMENT DE LA NÉPHRITE DE LUPUS À L'AIDE DU LAQUINIMOD
German Title of Invention:
BEHANDLUNG VON LUPUS NEPHRITIS MIT LAQUINIMOD
SPC Number:

Dates

Filing date:
02/03/2011
Grant date:
07/10/2015
EP Publication Date:
07/10/2015
PCT Publication Date:
09/09/2011
Claims Translation Received Date:
Translations Received Date (B1 EP Publication):
Translations Received Date (B2 EP Publication):
Translations Received Date (B3 EP Publication):
Publication date:
09/01/2013
EP B1 Publication Date:
07/10/2015
EP B2 Publication Date:
EP B3 Publication Date:
Lapsed date:
02/03/2016
Expiration date:
02/03/2031
Renunciation date:
Revocation date:
Annulment date:

Owner

From:
02/03/2011
 
 

Name:
Teva Pharmaceutical Industries Ltd.
Address:
5 Basel Street P.O. Box 3190, 49131 Petach-Tikva, Israel (IL)

Inventor

1

Name:
HAVIV Asi
Address:
Israel (IL)

2

Name:
TARCIC Nora
Address:
Israel (IL)

Priority

Priority Number:
339363 P
Priority Date:
03/03/2010
Priority Country:
United States (US)

Classification

Main IPC Class:
A61K 31/47;

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
Last Annual Fee Paid Number:
Payer:
Filing date Document type Number of pages